Lowey Dannenberg Notifies ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

Lawsuit Overview - A class action lawsuit has been filed against ASP Isotopes Inc (NASDAQ: ASPI) for alleged violations of federal securities laws [1] - The lawsuit covers investors who purchased ASP Isotopes common stock between October 30, 2024 and November 26, 2024 [1] Allegations Against ASP Isotopes - The company allegedly made false and/or misleading statements during the class period [2] - ASP Isotopes is accused of overstating the effectiveness of its enrichment technology [2] - The company allegedly overstated the development potential of its high assay low-enriched uranium facility [2] - ASP Isotopes is accused of overstating its nuclear fuels operating segment results [2] - These alleged misrepresentations made the company's positive statements about its business, operations, and prospects materially misleading [2] Impact on Investors - ASP Isotopes' common stock declined significantly when the truth was revealed, causing investor losses [3] - Investors who suffered losses exceeding $100,000 in ASP Isotopes securities are eligible to participate in the lawsuit [3] Legal Representation - Lowey Dannenberg P C, the law firm handling the case, has significant experience in prosecuting multi-million-dollar lawsuits [4] - The firm has recovered billions of dollars on behalf of its clients in similar cases [4]